<DOC>
	<DOCNO>NCT00005772</DOCNO>
	<brief_summary>This large multicenter trial test whether cerebral cooling initiate within 6 hour birth continue 72 hour would reduce risk death moderate severe neurodevelopmental injury 18-22 month correct age . Infants least 36 week gestation abnormal blood gas within 1 hour birth , history acute perinatal event 10-min Apgar score &lt; 5 , continue need ventilation screen . Following neurological exam , moderate severe encephalopathy randomize 72-hour period total body cooling ( cool blanket , follow slow re-warming ) . The study conduct two phase : Phase I ( 20 infant ) examine safety esophageal temperature 34-35 C ; Phase II ( main trial , 200 infant ) evaluate safety efficacy esophageal temperature 33-34 C. Cardio-respiratory , electroencephalogram ( EEGs ) , renal , metabolic , hematologic status , esophageal abdominal skin temperature monitor 72 hour intervention . Surviving child give neurodevelopmental examination 18-22 month correct age school age ( 6-7 year age ) .</brief_summary>
	<brief_title>Whole-Body Cooling Birth Asphyxia Term Infants</brief_title>
	<detailed_description>Perinatal cerebral hypoxia-ischemia injury important cause death neurodevelopmental disability . Data animal model suggest brain cooling immediately injury neuroprotective . Experience total body cool surgery , accidental near drownings , one Phase I trial term infant suggest effective safe child . This large multicenter trial test whether cerebral cooling initiate within 6 hour birth continue 72 hour would reduce risk death moderate severe neurodevelopmental injury 18-22 month correct age . Infants least 36 week gestation abnormal blood gas within 1 hour birth , history acute perinatal event 10-min Apgar score &lt; 5 , continue need ventilation screen . Following neurological exam , moderate severe encephalopathy randomize 72-hour period total body cooling ( cool blanket , follow slow re-warming ) . The study conduct two phase : Phase I ( 20 infant ) examine safety esophageal temperature 34-35 C ; Phase II ( main trial , 200 infant ) evaluate safety efficacy esophageal temperature 33-34 C. Cardio-respiratory , electroencephalogram ( EEGs ) , renal , metabolic , hematologic status , esophageal abdominal skin temperature monitor 72 hour intervention . Neurodevelopmental outcome assess 18-22 mos age mask certified examiner . The outcome 18-22 month show whole-body cooling reduces risk death moderate severe disability infant hypoxic ischemic encephalopathy . Surviving infant assess 6-7 year ( school age ) .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Hypoxia-Ischemia , Brain</mesh_term>
	<criteria>At least 36 week gestation Any blood gas ( cord , postnatal ) do within first 60 minute pH less equal 7.0 Any blood gas ( cord postnatal ) do within first 60 minute base deficit great equal 16 mEq/L All infant must seizures sign moderate severe encephalopathy randomization Inability randomize 6 hour age Presence know chromosomal anomaly major congenital anomaly Severe intrauterine growth restriction ( weight less 1800g ) All blood gas do within first 60 minute pH less 7.15 base deficit le 10 mEq/L Infants extremis additional intensive therapy offer attend neonatologist Parents refuse consent Attending neonatologist refuse consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Hours</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>NICHD Neonatal Research Network</keyword>
	<keyword>Hypoxic-ischemic encephalopathy ( HIE )</keyword>
	<keyword>Hypothermia</keyword>
	<keyword>Neonatal depression</keyword>
	<keyword>Perinatal asphyxia</keyword>
</DOC>